Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B

Since its introduction in the 1990s, liposomal amphotericin B (LAmB) continues to be an important agent for the treatment of invasive fungal diseases caused by a wide variety of yeasts and molds. This liposomal formulation was developed to improve the tolerability of intravenous amphotericin B, whil...

Full description

Saved in:
Bibliographic Details
Published in:Clin Infect Dis
Main Authors: Groll, Andreas H, Rijnders, Bart J A, Walsh, Thomas J, Adler-Moore, Jill, Lewis, Russell E, Brüggemann, Roger J M
Format: Artigo
Language:Inglês
Published: Oxford University Press 2019
Subjects:
Supplement Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6495018/
https://ncbi.nlm.nih.gov/pubmed/31222253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz076
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items